Levaquin Side Effects, Interactions, Dosage, Uses

Levaquin is a brand name for the antibiotic drug levofloxacin. Levofloxacin is a type of fluoroquinolone antibiotic used to treat various bacterial infections. It works by interfering with the growth and reproduction of bacteria, thus helping the body’s immune system to eliminate the infection. Levaquin is prescribed for a range of infections, including those affecting the respiratory tract, urinary tract, skin, sinuses, and other parts of the body. It’s important to note that antibiotics should be used only as directed by a healthcare professional and should not be used to treat viral infections like the common cold or flu.

How it works

Levofloxacin is categorized as a fluoroquinolone antibiotic medication. A drug class is a collection of medicines that share comparable modes of action. These medications are frequently employed to address comparable medical conditions.

Levofloxacin operates by eradicating the bacteria responsible for an infection. It’s imperative to solely employ this medication for treating bacterial infections.

The oral tablet form of levofloxacin has the potential to induce feelings of dizziness and a sensation of lightheadedness. Engaging in activities such as driving, operating machinery, or tasks demanding alertness and coordination should be avoided until one comprehends its impact on them.

Read Also: A Comprehensive Antenatal Drugs List in Nigeria

Side Effects

  1. Disabling and Possibly Irreversible Serious Side Effects That Might Occur Together: Patients should be informed that severe adverse reactions, which could be disabling and potentially irreversible, including conditions like tendinitis, tendon rupture, peripheral neuropathies, and central nervous system effects, have been associated with the use of LEVAQUIN®. These reactions might occur simultaneously in the same patient. Patients should discontinue LEVAQUIN® immediately and contact their healthcare provider if they experience any adverse reactions.
  2. Tendinitis and Tendon Rupture: Patients should be advised to get in touch with their healthcare provider if they encounter symptoms such as pain, swelling, or inflammation in a tendon, or experience weakness or loss of function in a joint. They should also cease LEVAQUIN® treatment, avoid exercise, and rest. These symptoms could be irreversible. The risk of severe tendon issues linked to fluoroquinolones is greater in older patients, typically those over 60 years of age, individuals taking corticosteroid medications, and those who have undergone kidney, heart, or lung transplants.
  3. Peripheral Neuropathies: Patients should be made aware that peripheral neuropathies have been linked to the use of levofloxacin. These symptoms might manifest shortly after starting the treatment and could be irreversible. If signs of peripheral neuropathy, such as pain, burning, tingling, numbness, and weakness, develop, patients should discontinue LEVAQUIN® immediately and consult their physician.
  4. Central Nervous System Effects (e.g., seizures, dizziness, increased intracranial pressure): Patients should be informed that seizures have been reported in individuals taking fluoroquinolones, including levofloxacin. Patients with a history of seizures should notify their physician before starting this medication. Patients should also be cautioned about operating vehicles or machinery or engaging in activities requiring mental alertness and coordination until they understand how they react to LEVAQUIN®. If persistent headaches, with or without blurred vision, occur, patients should inform their physician.
  5. Worsening of Myasthenia Gravis: Patients should be instructed to inform their doctor if they have a history of myasthenia gravis. If they experience muscle weakness, including difficulty breathing, they should promptly notify their physician.
  6. Hypersensitivity Reactions: Patients should be aware that levofloxacin can trigger hypersensitivity reactions, even after just one dose. They should discontinue the medication at the first sign of a skin rash, hives, rapid heartbeat, difficulty swallowing or breathing, swelling (e.g., lips, tongue, face), or other allergic symptoms.
  7. Liver Toxicity: Patients should be informed about the possibility of severe liver toxicity, including acute hepatitis and fatal events, associated with LEVAQUIN® usage. If they experience any signs of liver injury, such as loss of appetite, nausea, vomiting, fever, weakness, tiredness, tenderness in the upper right abdomen, itching, yellowing of skin/eyes, light-coloured bowel movements, or dark-coloured urine, they should notify their physician.
  8. Diarrhea: Diarrhea is a common side effect of antibiotics that usually resolves upon discontinuation of the antibiotic. In some cases, patients may develop watery and bloody stools, along with stomach cramps and fever, even several months after finishing the antibiotic. If this occurs, patients should contact their physician promptly.
  9. Prolongation of the QT Interval: Patients should inform their doctor of any personal or family history of QT prolongation or conditions that could predispose them to arrhythmias. If they are taking specific antiarrhythmic medications, they should also notify their physician. Patients should report any symptoms of prolonged QT interval, such as prolonged heart palpitations or loss of consciousness.
  10. Musculoskeletal Issues in Pediatric Patients: Parents should inform their child’s doctor if the child has a history of joint-related problems before starting LEVAQUIN®. If joint-related problems arise during or after levofloxacin therapy, parents of pediatric patients should promptly notify the child’s physician.
  11. Photosensitivity/Phototoxicity: Patients should be informed that photosensitivity/phototoxicity can occur with fluoroquinolone treatment. They should minimize exposure to natural or artificial sunlight and take protective measures if they need to be outdoors. If sunburn-like reactions or skin eruptions occur, patients should contact their physician.

Levaquin Dosage

The typical dosage of Levaquin ranges from 250 to 750 mg, administered once daily for a period of 5 to 60 days, depending on the nature of the infection.

Interactions with Other Drugs, Substances, or Supplements

Levaquin may interact with antacids containing magnesium or aluminium, sucralfate, didanosine, vitamin or mineral supplements containing iron or zinc, blood thinners, insulin or oral diabetes medications, theophylline, antibiotics, antidepressants, anti-malaria medications, medications used to prevent or treat nausea and vomiting, psychiatric disorder medications, migraine headache medications, narcotics, nonsteroidal anti-inflammatory drugs (NSAIDs), or steroids. It is vital to inform your healthcare provider about all medications and supplements you are using.

Levaquin During Pregnancy and Breastfeeding

Levaquin’s impact on pregnant women hasn’t been sufficiently evaluated, and it is not recommended for use by breastfeeding women due to the potential risk of adverse effects in the infant.

Additional Details

Our Levaquin Side Effects Drug Center offers a comprehensive overview of available drug information regarding potential side effects associated with the use of this medication.

Conclsuion

In conclusion, understanding the properties and effects of Levofloxacin, a fluoroquinolone antibiotic, is vital for its safe and effective use. Its classification within a drug class signifies shared mechanisms among medications for similar conditions. The primary action of Levofloxacin involves combating bacterial infections, emphasizing the importance of its selective application.

Users of the oral tablet form should remain cautious of potential dizziness and lightheadedness, refraining from activities demanding heightened alertness and coordination until their personal response is ascertained. By adhering to these guidelines, individuals can optimize the benefits of Levofloxacin while minimizing associated risks.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Web Times is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – webtimes.uk. The content will be deleted within 24 hours.

Leave a Comment